phase readout
saveNCT03233139: Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies
ACTIVE_NOT_RECRUITINGupdated 56m ago
community read0 votes
Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Advanced Malignancies
view source ↗
comments(0)
5-min edit window · permanent after that